Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice
- PMID: 6609767
Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice
Abstract
During the course of the L5178Y tumor-dormant state in DBA/2 mice, there is continual selection of a tumor cell subpopulation ("emergent" phenotype) from the uncloned original L5178Y population used to initiate the tumor-dormant state. In vivo and in vitro experiments show that the emergent-phenotype tumor cells are less capable than "original"-phenotype cells, which constitute the majority of the L5178Y cell inoculum, of restimulating cytolytic T-lymphocyte (CTL) activity in tumor-dormant mice and are less susceptible to lysis by those CTL. Both original- and emergent-phenotype tumor cells are capable of eliciting an immune CTL response in naive mice, but again emergent-phenotype cells are poorly lysed by this response. As a consequence of these characteristics, emergent-phenotype cells rapidly form ascitic tumors when used as a challenge in L5178Y cell-immunized mice and cannot establish a tumor-dormant state. Results presented here and in previous publications indicate that CTLs are the major host cells involved in the selection of emergent-phenotype L5178Y cells during the course of the tumor-dormant state. Heterogeneity of the tumor cell challenge inoculum is important in establishing the L5178Y tumor-dormant state. The state, once established, is maintained by an immune CTL response which is continuously being restimulated by the strongly immunogenic original-phenotype L5178Y cells. The tumor-dormant state terminates when the less immunogenic and more immunoresistant emergent-phenotype tumor cells predominate and escape the waning immune response.
Similar articles
-
Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.Cancer Res. 1984 Mar;44(3):1063-71. Cancer Res. 1984. PMID: 6607108
-
Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.Cancer Res. 1983 Dec;43(12 Pt 1):5831-6. Cancer Res. 1983. PMID: 6227383
-
Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.Cancer Res. 1982 Sep;42(9):3607-16. Cancer Res. 1982. PMID: 6179603
-
Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.Cancer Res. 1983 Jan;43(1):15-21. Cancer Res. 1983. PMID: 6600159
-
Developmental changes during the formation and breaking of the dormant state in bacteria.Annu Rev Microbiol. 1966;20:169-88. doi: 10.1146/annurev.mi.20.100166.001125. Annu Rev Microbiol. 1966. PMID: 5330231 Review. No abstract available.
Cited by
-
Implications of tumor progression on clinical oncology.Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88. doi: 10.1007/BF01786761. Clin Exp Metastasis. 1985. PMID: 3902300 Review. No abstract available.
-
Animal models of leukemia: any closer to the real thing?Cancer Metastasis Rev. 2013 Jun;32(1-2):63-76. doi: 10.1007/s10555-012-9405-5. Cancer Metastasis Rev. 2013. PMID: 23081702 Free PMC article. Review.
-
Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth.J Exp Med. 1986 Oct 1;164(4):1259-73. doi: 10.1084/jem.164.4.1259. J Exp Med. 1986. PMID: 3489807 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials